Method for treating tumors having high ldl requirements employing mtp inhibitors
CA 2261162 A1 · Owner: Firestone, Raymond A. · Inventors: Firestone, Raymond A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method is provided for treating hematologic tumors and solid tumors including certain types of leukemias and metastatic tumors having high LDL , requirements employing a delipidating agent such as an MTP inhibitor to substantially reduce LDL blood levels. In addition a method is provided for , treating tumors of the above types having high LDL requirements especially , hematologic tumors such as certain leukemias employing a delipidating , compound to substantially remove native LDL and then administering a , cytotoxic agent carried in reconstituted LDL.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 14, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 14, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 14, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.